Fas/FasL pathway participates in regulation of antiviral and inflammatory response during mousepox infection of lungs

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Bień, Karolina ^a   Sokołowska, Justyna ^b   Bąska, Piotr ^b   Nowak, Zuzanna ^b   Stankiewicz, Wanda ^a   Krzyzowska, Malgorzata ^a  

^a MILITARY INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Poland)

^b WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; CXCL9 CHEMOKINE; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 15; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; FAS PROTEIN, MOUSE; FASL PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW DERIVED MACROPHAGE; BRONCHUS MUCOSA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ECTROMELIA VIRUS; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; LUNG PARENCHYMA; MOUSE; MOUSEPOX; NATURAL KILLER CELL; NONHUMAN; PATHOGEN LOAD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; IMMUNOLOGY; LUNG; PHYSIOLOGY; T LYMPHOCYTE; VIROLOGY;

ECTROMELIA VIRUS; MUS;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CELL LINE; ECTROMELIA, INFECTIOUS; FAS LIGAND PROTEIN; FEMALE; INFLAMMATION; LUNG; MICE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84926649895     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/281613     Document Type: Article

References (45)

1. F. K.-M. Chan, H. J. Chun, L. Zheng, R. M. Siegel, K. L. Bui, and M. J. Lenardo, "A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling, " Science, vol. 288, no. 5475, pp. 2351-2354, 2000.
2. P. A. Henkart, M. S. Williams, C. M. Zacharchuk, and A. Sarin, "Do CTL kill target cells by inducing apoptosis?" Seminars in Immunology, vol. 9, no. 2, pp. 135-144, 1997.
3. E. Vivier, E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini, "Functions of natural killer cells, " Nature Immunology, vol. 9, no. 5, pp. 503-510, 2008.
4. T. A. Ferguson and T. S. Griffith, "A vision of cell death: fas ligand and immune privilege 10 years later, " Immunological Reviews, vol. 213, no. 1, pp. 228-238, 2006.
5. M. Ramaswamy, S. Y. Clel, A. C. Cruz, and R. M. Siegel, "Many checkpoints on the road to cell death: regulation of Fas-Fasl interactions and Fas signaling in peripheral immune responses, " Results and Problems in Cell Differentiation, vol. 49, pp. 17-47, 2009.
6. B. Shrestha and M. S. Diamond, "Fas ligand interactions contribute to CD8+ T-cell-mediated control of West Nile virus infection in the central nervous system, " Journal of Virology, vol. 81, no. 21, pp. 11749-11757, 2007.
7. D. J. Topham, R. A. Tripp, and P. C. Doherty, "CD8 T cells clear influenza virus by perforin or Fas-dependent processes, " Journal of Immunology, vol. 159, no. 11, pp. 5197-5200, 1997.
8. A. J. Johnson, C.-F. Chu, and G. N. Milligan, "Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords, " Journal of Virology, vol. 82, no. 19, pp. 9678-9688, 2008.
9. M. Krzyzowska, A. Shestakov, K. Eriksson, and F. Chiodi, "Role of Fas/FasL in regulation of inflammation in vaginal tissue during HSV-2 infection, " Cell Death and Disease, vol. 2, article e132, 2011.
10. B. Parra, M. T. Lin, S. A. Stohlman, C. C. Bergmann, R. Atkinson, and D. R. Hinton, "Contributions of Fas-Fas ligand interactions to the pathogenesis of mouse hepatitis virus in the central nervous system, " Journal of Virology, vol. 74, no. 5, pp. 2447-2450, 2000.
11. M. M. Stanford, G. McFadden, G. Karupiah, and G. Chaudhri, "Immunopathogenesis of poxvirus infections: forecasting the impending storm, " Immunology and Cell Biology, vol. 85, no. 2, pp. 93-102, 2007.
12. I. S. Cespedes, F. N. Toka, A. Schollenberger, M. Gierynska, and M. Niemiatowski, "Pathogenesis of mousepox in H-2 mice: evidence forMHC class I-restricted CD8+ andMHCclass II-restricted CD4+ CTL antiviral activity in the lymph nodes, spleen and skin, but not in the conjunctivae, " Microbes and Infection, vol. 3, no. 13, pp. 1063-1072, 2001.
13. D. J. Esteban and R. M. L. Buller, "Ectromeliavirus: the causative agent of mousepox, " Journal of General Virology, vol. 86, no. 10, pp. 2645-2659, 2005.
14. G. Chaudhri, V. Panchanathan, R. M. L. Buller et al., "Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox, " Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 24, pp. 9057-9062, 2004.
15. R. O. Jacoby, P. N. Bhatt, and D. G. Brownstein, "Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus, " Archives of Virology, vol. 108, no. 1-2, pp. 49-58, 1989.
16. M. L. Delano and D. G. Brownstein, "Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype, " Journal of Virology, vol. 69, no. 9, pp. 5875-5877, 1995.
17. S. Mahalingam, G. Karupiah, K. Takeda, S. Akira, K. I. Matthaei, and P. S. Foster, "Enhanced resistance in STAT6-deficient mice to infection with ectromelia virus, " Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 12, pp. 6812-6817, 2001.
18. J. A. Trapani, D. A. Jans, P. J. Jans, M. J. Smyth, K. A. Browne, and V. R. Sutton, "Efficient nuclear targeting of granzyme B and the nuclear consequences of apoptosis induced by granzyme B and perforin are caspase-dependent, but cell death is caspaseindependent, " The Journal of Biological Chemistry, vol. 273, no. 43, pp. 27934-27938, 1998.
19. M. Fang, N. A. Siciliano, A. R. Hersperger et al., "Perforindependent CD4+ T-cell cytotoxicity contributes to control a murine poxvirus infection, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 25, pp. 9983-9988, 2012.
20. S. J. Turner, J. Silke, B. Kenshole, and J. Ruby, "Characterization of the ectromelia virus serpin, SPI-2, " Journal of General Virology, vol. 81, no. 10, pp. 2425-2430, 2000.
21. M. Krzyzowska, J. Cymerys, A. Winnicka, and M. Niemiatowski, "Involvement of Fas and FasL in Ectromelia virus-induced apoptosis in mouse brain, " Virus Research, vol. 115, no. 2, pp. 141-149, 2006.
22. M. Krzyzowska, M. Polanczyk, M. Bas et al., "Mousepox conjunctivitis: the role of Fas/FasL-mediated apoptosis of epithelial cells in virus dissemination, " Journal ofGeneralVirology, vol. 86, no. 7, pp. 2007-2018, 2005.
23. S. Mocellin, "Targeting death receptors to fight cancer: from biological rational to clinical implementation, " Current Medicinal Chemistry, vol. 17, no. 25, pp. 2713-2728, 2010.
24. M. Krzyzowska, A. Schollenberger, J. Skierski, and M. Niemiatowski, "Apoptosis during ectromelia orthopoxvirus infection is DEVDase dependent: in vitro and in vivo studies, " Microbes and Infection, vol. 4, no. 6, pp. 599-611, 2002.
25. A. Gunalp, "Growth and cytopathic effect of rubella virus in a line of greenmonkey kidney cells, " Proceedings of the Society for Experimental Biology and Medicine, vol. 118, pp. 185-190, 1965.
26. H. Meyer, I. K. Damon, and J. J. Esposito, "Orthopoxvirus diagnostics, " in Vaccinia Virus and Poxvirology, vol. 269 of Methods in Molecular Biology, pp. 119-133, Humana Press, Totowa, NJ, USA, 2004.
27. Y. Y. Foong, D. A. Jans, M. S. Rolph, M. E. Gahan, and S. Mahalingam, "Interleukin-15 mediates potent antiviral responses via an interferon-dependent mechanism, " Virology, vol. 393, no. 2, pp. 228-237, 2009.
28. F. Fenner, "Mouse-pox (infectious ectromelia of mice): a review, " Journal of Immunology, vol. 63, no. 4, pp. 341-373, 1949.
29. A. Strasser, P. J. Jost, and S. Nagata, "The many roles of FAS receptor signaling in the immune system, " Immunity, vol. 30, no. 2, pp. 180-192, 2009.
30. K. L. Legge and T. J. Braciale, "Lymph node dendritic cells control CD8+ T cell responses through regulated FasL expression, " Immunity, vol. 23, no. 6, pp. 649-659, 2005.
31. G. Matute-Bello, J. S. Lee, W. C. Liles et al., "Fas-mediated acute lung injury requires Fas expression on nonmyeloid cells of the lung, " Journal of Immunology, vol. 175, no. 6, pp. 4069-4075, 2005.
32. A. Müllbacher, R. Wallich, R. W. Moyer, and M. M. Simon, "Poxvirus-encoded serpins do not prevent cytolytic T cellmediated recovery from primary infections, " The Journal of Immunology, vol. 162, no. 12, pp. 7315-7321, 1999.
33. C. A. Biron, K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather, "Natural killer cells in antiviral defense: function and regulation by innate cytokines, " Annual Review of Immunology, vol. 17, pp. 189-220, 1999.
34. A. K. Parker, S. Parker, W. M. Yokoyama, J. A. Corbett, and R. M. L. Buller, "Induction of natural killer cell responses by ectromelia virus controls infection, " Journal of Virology, vol. 81, no. 8, pp. 4070-4079, 2007.
35. M. Fang, L. L. Lanier, and L. J. Sigal, "A role for NKG2D in NK cell-mediated resistance to poxvirus disease, " PLoS Pathogens, vol. 4, no. 2, article e30, 2008.
36. G. Karupiah, T. N. Fredrickson, K. L. Holmes, L. H. Khairallah, and R. M. L. Buller, "Importance of interferons in recovery from mousepox, " Journal of Virology, vol. 67, no. 7, pp. 4214-4226, 1993.
37. K. Mossman, C. Upton, R. M. L. Buller, and G. McFadden, "Species specificity of ectromelia virus and vaccinia virus interferon-γ binding proteins, " Virology, vol. 208, no. 2, pp. 762-769, 1995.
38. G. Karupiah, R. M. L. Buller, N. Van Rooijen, C. J. Duarte, and J. Chen, "Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection, " Journal of Virology, vol. 70, no. 12, pp. 8301-8309, 1996.
39. M. Krzyzowska, P. Baska, and P. Orlowski, "HSV-2 regulates monocyte inflammatory response via the Fas/FasL pathway, " PLoS ONE, vol. 8, no. 7, Article ID e70308, 2013.
40. M. Krzyzowska, P. Orowski, P. Bska, P. Bodera, R. Zdanowski, and W. Stankiewicz, "Role of Fas/FasL signaling in regulation of anti-viral response during HSV-2 vaginal infection in mice, " Immunobiology, vol. 219, no. 12, pp. 932-943, 2014.
41. M. K. Park, D. Amichay, P. Love et al., "The CXC chemokine murine monokine induced by IFN-γ (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo, " The Journal of Immunology, vol. 169, no. 3, pp. 1433-1443, 2002.
42. G. Trinchieri, "Regulatory role of T cells producing both interferon γ and interleukin 10 in persistent infection, " Journal of Experimental Medicine, vol. 194, no. 10, pp. F53-F57, 2001.
43. W. Chen, W. Jin, N. Hardegen et al., "Conversion of peripheral CD4+CD25? naive T Cells to CD4+CD25+ regulatory T Cells by TGF-β induction of transcription factor Foxp3, " Journal of Experimental Medicine, vol. 198, no. 12, pp. 1875-1886, 2003.
44. S. W. Chensue, "Molecular machinations: chemokine signals in host-pathogen interactions, " ClinicalMicrobiology Reviews, vol. 14, no. 4, pp. 821-835, 2001.
45. Y. Kitamura, S. Hashimoto, N. Mizuta et al., "Fas/fasLdependent apoptosis of alveolar cells after lipopolysaccharideinduced lung injury in mice, " American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 3 I, pp. 762-769, 2001.